Skip to main content
Equibles
KROS logo

KROS · Keros Therapeutics, Inc. · Share Buybacks

Track KROS — free

Use KROS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KROS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.08 +0.54 (+5.66%) At close · Nov 12
Russell 2000 member Rebalance outlook locked
Market Cap
$197.81M
Shares
19.62M
Volume · Nov 12 630.16K Avg daily vol (3M) 187.94K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$5,000,000
as of 2026-09-08 · from 8-K (reviewed)
Remaining Authorization
$3,400,000
as of 2026-09-30
Program Utilization
32.0% $1,600,000 used of $5,000,000
Program Announced Authorized Remaining Runs Through
2026-09-08 $5,000,000 — —

Repurchase History

Fiscal Year Ended Cash Spent
2026-09-30 YTD $1,545,000
2025-12-31 $375,000,000
2024-12-31 $0
Key facts CIK 1664710 CUSIP 492327101 13F (30d) 85 filings 70 filers Visit website Investor relations